We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$571M
AUM Growth
+$64.7M
(+13%)
Cap. Flow
+$77M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$35.4M |
| 2 |
Stellantis
STLA
|
+$22.2M |
| 3 |
PepsiCo
PEP
|
+$18M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$6.64M |
| 5 |
Kohl's
KSS
|
+$5.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$21.5M |
| 2 |
iShares MSCI Indonesia ETF
EIDO
|
+$11.1M |
| 3 |
Eaton
ETN
|
+$4.76M |
| 4 |
Delta Air Lines
DAL
|
+$4.4M |
| 5 |
Western Union
WU
|
+$4.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.66% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Consumer Staples | 8.41% |
| 4 | Energy | 8.01% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UBS Group
UBS
$170B
| $45.2M | 7.93% |
3,805,878
+2,886,544
| +314% | +$35.4M |
|
|
2
PepsiCo
PEP
$196B
| $26.2M | 4.6% |
199,123
+140,351
| +239% | +$18M |
|
|
3
Stellantis
STLA
$17.4B
| $21.6M | 3.78% |
+1,528,258
| New | +$22.2M |
|
4
PUT
Deutsche Bank
DB
$66.6B
| $18.6M | 3.26% |
25,657
-12,900
| -33% | -$99.5K |
|
|
RSX
5
DELISTED
VanEck Russia ETF
RSX
| $14.9M | 2.61% |
629,731
-44,673
| -7% | -$978K |
|
6
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $14.9M | 2.61% |
346,647
+2,148
| +0.6% | +$91.2K |
|
|
7
Deutsche Bank
DB
$66.6B
| $12.2M | 2.15% |
1,588,820
+671,935
| +73% | +$5.18M |
|
|
8
PUT
UBS Group
UBS
$170B
| $12M | 2.1% |
71,923
-11,216
| -13% | -$137K |
|
9
iShares MSCI Mexico ETF
EWW
$1.89B
| $11.9M | 2.09% |
275,128
+86,290
| +46% | +$3.87M |
|
10
iShares MSCI Philippines ETF
EPHE
$132M
| $10.3M | 1.8% |
288,512
+5,243
| +2% | +$181K |
|
11
iShares MSCI China ETF
MCHI
$6.23B
| $8.76M | 1.54% |
147,454
+41,542
| +39% | +$2.5M |
|
|
12
CALL
PepsiCo
PEP
$196B
| $7.74M | 1.36% |
3,150
-2,374
| -43% | -$304K |
|
|
13
PUT
Stellantis
STLA
$17.4B
| $7.34M | 1.29% |
11,830
+540
| +5% | +$7.84K |
|
14
SPDR Gold Trust
GLD
$131B
| $7.21M | 1.26% |
54,133
+16,326
| +43% | +$2.02M |
|
15
TechnipFMC
FTI
$28.6B
| $6.85M | 1.2% |
358,024
-131,871
| -27% | -$2.31M |
|
|
16
iShares MSCI Saudi Arabia ETF
KSA
$612M
| $6.51M | 1.14% |
+197,335
| New | +$6.64M |
|
|
17
Kohl's
KSS
$2.16B
| $6.23M | 1.09% |
131,146
+85,922
| +190% | +$5.18M |
|
18
BCE
BCE
$20.8B
| $6.05M | 1.06% |
132,960
-36,800
| -22% | -$1.66M |
|
19
AB InBev
BUD
$164B
| $5.73M | 1.01% |
64,815
+50,125
| +341% | +$4.3M |
|
20
Seagate
STX
$174B
| $4.6M | 0.81% |
97,754
+96,590
| +8,298% | +$4.49M |
|
|
GAP
21
The Gap Inc
GAP
$7.3B
| $4.57M | 0.8% |
254,582
+145,775
| +134% | +$3.27M |
|
22
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $4.54M | 0.8% |
15,500
+3,416
| +28% | +$984K |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $4.43M | 0.78% |
26,440
+25,679
| +3,374% | +$3.56M |
|
24
Cummins
CMI
$83.6B
| $4.39M | 0.77% |
25,651
-5,345
| -17% | -$875K |
|
25
Merck
MRK
$322B
| $4.35M | 0.76% |
54,391
-3,496
| -6% | -$268K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2019 Portfolio in Review
As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.
- Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
- Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
- Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
- Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
- Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
- Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
- Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.
Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.